← Open Payments lookup

MONICA DHADUK: Open Payments

NPI 1598473092 · FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$239 in 13 payments from 10 companies in 2025. Trend: 2023 $1,916 · 2024 $1,478 · 2025 $239

Food & beverage: $239
CompanyPaymentsAmount
Lilly USA, LLC2$39
GlaxoSmithKline, LLC.2$34
AstraZeneca Pharmaceuticals LP2$34
Averitas Pharma Inc.1$31
Seqirus USA Inc1$22
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$19
Bayer Healthcare Pharmaceuticals Inc.1$17
Boehringer Ingelheim Pharmaceuticals, Inc.1$15
TOLMAR, INC.1$14
Amgen Inc.1$14

Products named: MOUNJARO, AIRSUPRA, QUTENZA, Flucelvax, XIFAXAN, SHINGRIX, Kerendia, TRELEGY ELLIPTA.

Industry payments across MD — which companies pay providers there.